Xcout IntelCeriBell, Inc. competitors & alternatives
The 12 closest competitors and alternatives to CeriBell, Inc. among medical devices companies — ranked by similarity to what CeriBell, Inc. actually does, not by market-cap band.
Subscribe to see CeriBell, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
CeriBell, Inc. at a glance
CeriBell, Inc. is a medical devices company headquartered in Sunnyvale, United States. It is publicly listed (CBLL) with a market capitalisation of $896.6M. Xcout tracks 28 named people at CeriBell, Inc., including Scott Blumberg (Chief Financial Officer). Xcout recorded 93 job postings from CeriBell, Inc. in the last 90 days.
CeriBell, Inc. leadership
- Scott BlumbergChief Financial Officer
- Raymond WooChief Technology Officer
- Joseph S. ManniChief Revenue Officer
- Sean ManniChief Revenue Officer
- Louisa DanielsGeneral Counsel
- Xingjuan ChaoCo-Founder, President, Chief Executive Officer & Director
22 more named people on record for CeriBell, Inc., with roles, board committees and tenure — see the full roster →
CeriBell, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C-1 | $100.4M | 6 named | |
| Series C | $102.5M | 1 named | |
| Series B | $35M | 3 named |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at CeriBell, Inc.
Xcout recorded 93 job postings from CeriBell, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see CeriBell, Inc.'s hiring signals →
Top 12 CeriBell, Inc. competitors
Ranked by semantic similarity — how close each company is to CeriBell, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Iaso AI INC is a medical device company that is developing a machine learning-powered platform for the early detection and management of Acute Respiratory Distress Syndrome (ARDS) in intensive care units. The company serves critical care teams, including intensivists, doctors, and nurses, by providing automated early warning systems to enable timely intervention for critically ill patients.
Similar medical devices company
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
Similar medical devices company
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
Health Care Equipment & Services
Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East. The company's product portfolio is primarily focused on solutions for sleep and neurological disorders. For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S. for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO). Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler. Other software offerings include HD Digital Video integration and various specialized applications. Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors. Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Health Care Equipment & Services
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
Health Care Equipment & Services
BlinkLab Limited, founded by neuroscientists, has developed a smartphone-based diagnostic platform for neurodevelopmental conditions like autism and ADHD. The technology uses AI and machine learning for screening tests in children as young as 18 months, aiming for earlier detection and intervention. The company is pursuing FDA approval to facilitate broader use of its technology.
Similar medical devices company
Mindwave Medical, Inc. provides a silent hospital alarm system designed for healthcare facilities and staff. The system utilizes lightweight bone conduction headsets, presence detection, and automatic device location to route alarm audio directly to responsible staff members, reducing ambient noise while maintaining safety protocols.
Similar medical devices company
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Similar medical devices company
Blackrock Neurotech develops innovative brain-computer interface technologies designed to restore function, communication, and movement for individuals with paralysis and neurological disorders.
Similar medical devices company
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.
Similar medical devices company
Cerenovus, a part of Johnson & Johnson MedTech, is a global leader in neurovascular care. The company is dedicated to changing the trajectory of stroke.
Similar medical devices company
ClearPoint Neuro, Inc. is a global medical device, cell, and gene therapy-enabling company headquartered in Solana Beach, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CeriBell, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CeriBell, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →